πŸ‡ΊπŸ‡Έ FDA
Patent

US 6897305

Calcium channel drugs and uses

expired A61KA61K47/545A61K47/55

Quick answer

US patent 6897305 (Calcium channel drugs and uses) held by Theravance, Inc. expires Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue May 24 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K47/545, A61K47/55, A61K47/65